FORA|Forian Inc|Price:2.090|

More Details of Forian Inc Company

Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.

Forian Inc Info



Ticker SymbolFORA

Company nameForian Inc

IPO dateMar 03, 2021

CEOWygod (Max)

Number of employees1

Security typeOrdinary Share

Fiscal year-endMar 03

Address41 University Drive

CityNEWTOWN

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code18940

Phone12677578707

Websitehttps://forian.com/

Ticker SymbolFORA

IPO dateMar 03, 2021

CEOWygod (Max)

Company Executives of Forian Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Shahir Kassam-Adams

Independent Director

174.93K

--

Dr. Mark J. Adler, M.D.

Independent Director

36.33K

--

Ms. Jennifer Hajj

Independent Director

10.00K

--

Ms. Alyssa F. Varadhan

Independent Director

5.00K

--

Mr. Max Wygod

Executive Chairman of the Board, President, Chief Executive Officer

--

Mr. Adam Dublin

Chief Strategy Officer, Director

--

Mr. Ian G. Banwell

Independent Director

--

Dr. Kristiina S. Vuori, M.D., Ph.D.

Independent Director

--

Mr. Michael T. (Mike) Vesey

Chief Financial Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Shahir Kassam-Adams

Independent Director

174.93K

--

Dr. Mark J. Adler, M.D.

Independent Director

36.33K

--

Ms. Jennifer Hajj

Independent Director

10.00K

--

Ms. Alyssa F. Varadhan

Independent Director

5.00K

--

Mr. Max Wygod

Executive Chairman of the Board, President, Chief Executive Officer

--

Mr. Adam Dublin

Chief Strategy Officer, Director

--

Revenue Breakdown

Currency: USDUpdated: Sun, Apr 6

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

By BusinessUSD

Name

Revenue

Proportion

Healthcare Information

16.42M

58.62%

Software Subscriptions

9.77M

34.88%

Services

1.55M

5.52%

Other

274.26K

0.98%

Relevant data have not been disclosed by the company yet.

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Healthcare Information

16.42M

58.62%

Software Subscriptions

9.77M

34.88%

Services

1.55M

5.52%

Other

274.26K

0.98%

Shareholding Stats

Updated: Fri, Jan 30

Shareholders

Shareholder Types

Shareholders

Proportion

Vuolo (Anthony)

12.92%

Wygod (Max C)

12.42%

Dublin (Adam H)

7.74%

The Adam H. Dublin 2019 Family Trust.

5.89%

Oracle Investment Management, Inc.

4.40%

Other

56.62%

Shareholders

Proportion

Vuolo (Anthony)

12.92%

Wygod (Max C)

12.42%

Dublin (Adam H)

7.74%

The Adam H. Dublin 2019 Family Trust.

5.89%

Oracle Investment Management, Inc.

4.40%

Other

56.62%

Shareholder Types

Shareholders

Proportion

Individual Investor

43.26%

Corporation

5.89%

Investment Advisor/Hedge Fund

5.31%

Hedge Fund

3.85%

Investment Advisor

3.13%

Research Firm

0.17%

Family Office

0.16%

Other

38.24%

Institutional Shareholding



Updated: Mon, Dec 8

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

52

4.14M

15.44%

--

2025Q3

53

4.14M

15.47%

--

2025Q2

56

4.14M

15.63%

-16.60K

2025Q1

58

4.16M

15.64%

-722.75K

2024Q4

60

4.75M

14.07%

+578.56K

2024Q3

58

4.17M

16.53%

-720.14K

2024Q2

68

4.89M

14.31%

+697.02K

2024Q1

100

4.19M

15.03%

-481.08K

2023Q4

99

4.19M

15.17%

+12.03K

2023Q3

100

4.18M

14.24%

+15.66K

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Vuolo (Anthony)

4.02M

12.92%

--

Dec 15, 2025

Wygod (Max C)

3.86M

12.42%

--

Dec 15, 2025

Dublin (Adam H)

2.41M

7.74%

-200.00K

-7.68%

Dec 15, 2025

The Adam H. Dublin 2019 Family Trust.

1.83M

5.89%

--

Dec 15, 2025

Oracle Investment Management, Inc.

1.37M

4.4%

--

Sep 30, 2025

Staley Capital Advisers, Inc.

1.10M

3.54%

--

Sep 30, 2025

Coleman (Thomas Jason)

908.48K

2.92%

--

Dec 31, 2024

Bushnell (Emily)

901.22K

2.9%

--

Dec 15, 2025

The Vanguard Group, Inc.

760.57K

2.45%

-14.57K

-1.88%

Sep 30, 2025

Spaniel (Edward Francis JR)

688.97K

2.22%

--

Dec 15, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

iShares Micro-Cap ETF

0.01%

Dimensional US Core Equity 1 ETF

0%

DFA Dimensional US Sustainability Core 1 ETF

0%

iShares Micro-Cap ETF

Proportion0.01%

Dimensional US Core Equity 1 ETF

Proportion0%

DFA Dimensional US Sustainability Core 1 ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data